Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Phenylthiourea is a synthetic organic compound belonging to the class of thioureas in which one hydrogen atom is replaced by a phenyl group. It acts as a competitive **inhibitor** of tyrosinase (also known as phenoloxidase), an enzyme involved in melanin biosynthesis and pigment formation. The inhibition constant (Ki) for tyrosinase is approximately 0.21 μM, indicating high potency[5][6]. N-Phenylthiourea has been used primarily as a laboratory reagent and research tool rather than as an approved pharmaceutical drug. Its applications include use as a precursor for synthesizing antibacterial and antifungal compounds, and it serves as a genetic marker for taste sensitivity because only some individuals can detect its bitter flavor[1][5]. Chronic exposure may have antithyroid activity and other toxic effects[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-Phenylthiourea.